Clovis CEO: We can win against AstraZeneca
June 03, 2014 at 13:16 PM EDT
Clovis shares fell to a 52-week low Tuesday on concerns its cancer drug won't be able to compete with rival AstraZeneca.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.